Central Venous Catheter Market By Product type, By Property, By Design, By End-User : Global Opportunity Analysis and Industry Forecast, 2023-2032

Description

List of Tables

According to a new report published by Allied Market Research, titled, "Central Venous Catheter Market," The central venous catheter market was valued at $2.6 billion in 2022, and is estimated to reach $4.7 billion by 2032, growing at a CAGR of 6.4% from 2023 to 2032.

Central venous catheters are defined as an indwelling device inserted into a large, central vein such as internal jugular, subclavian, or femoral. Central venous catheters are used for blood transfusion and infusion of chemotherapy drugs. These catheters are available with various numbers of lumens.

The growth of the central venous catheter market is driven by surge in incidence of cardiovascular diseases, increase in availability & affordability of healthcare treatment and rise in number of hospital admission. The increase in incidence of acute kidney injury and kidney failure drives the demand for central venous catheters. These catheters are used for hemodialysis. For instance, according to American Kidney Fund, in 2020, more than 562,000 Americans were on dialysis. Growth in a number of hemodialysis thus consequently drives the market growth.

Moreover, large medical technology firms have increasingly focused on acquiring companies that provide solutions for central venous catheters, which is expected to notably contribute toward the market growth. Prominent players in the global central venous catheter market have adopted various strategies such as product launches, acquisitions, and investments in R&D for advancement in central venous catheters to strengthen their position in the market and sustain the competitive environment. For instance, in January 2021, Shenzhen Prunus Technology Co., Ltd., acquired the critical care products division of Biosensors International Group, Ltd, officially entering the field of critical care consumables business. The acquired products of the subsidiary include central venous catheters, pressure transducers, pulmonary artery catheters, pacing catheters, thrombolysis catheters, urinary catheters, and other medical consumables.

Moreover, alarming increase in prevalence of kidney diseases, technological advancements in central venous catheter, and rise in the number of accidents and trauma are some of the key factors that drive the growth of the market. Furthermore, rise in geriatric population and changes in lifestyles notably contribute toward the growth in prevalence of diseases. However, concern related to catheter infections and product recalls by manufacturers is expected to hamper the market growth. Conversely, increased application of central venous catheter among the geriatric population and emergency health conditions is expected to provide lucrative opportunities for the growth of the market in the near future. In addition, extensive R&D activities in the field of central venous catheter along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market during the forecast period.

The central venous catheter market is segmented into product type, property, design, end user, and region. On the basis of product type, the market is bifurcated into tunneled catheters and non-tunneled catheters. On the basis of property, the market is bifurcated into antimicrobial catheters and non-antimicrobial catheters. On the basis of design, the market is classified into single lumen, double lumen and multiple lumens. On the basis of end user, it is classified into hospitals, cancer treatment centers, and others. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major companies profiled in the report include: AngioDynamics, Asahi Kasei Corporation., B. Braun, Becton Dickinson and Company, ICU Medical, Medtronic plc., Merit medical, Rex Medical, Teleflex Incorporated and Vygon Ltd.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the central venous catheter market analysis from 2022 to 2032 to identify the prevailing central venous catheter market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the central venous catheter market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global central venous catheter market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

New Product Development/ Product Matrix of Key Players
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Criss-cross segment analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)
SWOT Analysis

Key Market Segments

By Product type

Tunneled Catheters
Non-Tunneled Catheters

By Property

Antimicrobial Catheters
Non-Antimicrobial Catheters

By Design

Single Lumen
Double Lumen
Multiple Lumen

By End-User

Hospital
Cancer treatment centers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

B. Braun SE
ICU Medical Inc.
AngioDynamics, Inc.
Medtronic plc
Rex Medical, LLC.
Vygon
Asahi Kasei Corporation.
Becton, Dickinson and Company
Merit Medical Systems Inc.
Teleflex Incorporated

Product Code: A03016

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate intensity of rivalry
- 3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Rise in prevalence of chronic diseases
  - 3.4.1.2. Increase in healthcare expenditure and improvements in healthcare facilities
  - 3.4.1.3. Upsurge in geriatric population

3.4.2. Restraints
- 3.4.2.1. 3.4.2.1. Product recall by manufacturers

3.4.3. Opportunities
- 3.4.3.1. High growth potential in developing economies

3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: CENTRAL VENOUS CATHETER MARKET, BY PRODUCT TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Tunneled Catheters
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Non-Tunneled Catheters
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country

CHAPTER 5: CENTRAL VENOUS CATHETER MARKET, BY PROPERTY

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Antimicrobial Catheters
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Non-Antimicrobial Catheters
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country

CHAPTER 6: CENTRAL VENOUS CATHETER MARKET, BY DESIGN

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Single Lumen
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Double Lumen
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Multiple Lumen
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country

CHAPTER 7: CENTRAL VENOUS CATHETER MARKET, BY END-USER

7.1. Overview
- 7.1.1. Market size and forecast
7.2. Hospital
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
7.3. Cancer treatment centers
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
7.4. Others
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country

CHAPTER 8: CENTRAL VENOUS CATHETER MARKET, BY REGION

8.1. Overview
- 8.1.1. Market size and forecast By Region
8.2. North America
- 8.2.1. Key trends and opportunities
- 8.2.2. Market size and forecast, by Product type
- 8.2.3. Market size and forecast, by Property
- 8.2.4. Market size and forecast, by Design
- 8.2.5. Market size and forecast, by End-User
- 8.2.6. Market size and forecast, by country
  - 8.2.6.1. U.S.
  - 8.2.6.1.1. Key market trends, growth factors and opportunities
  - 8.2.6.1.2. Market size and forecast, by Product type
  - 8.2.6.1.3. Market size and forecast, by Property
  - 8.2.6.1.4. Market size and forecast, by Design
  - 8.2.6.1.5. Market size and forecast, by End-User
  - 8.2.6.2. Canada
  - 8.2.6.2.1. Key market trends, growth factors and opportunities
  - 8.2.6.2.2. Market size and forecast, by Product type
  - 8.2.6.2.3. Market size and forecast, by Property
  - 8.2.6.2.4. Market size and forecast, by Design
  - 8.2.6.2.5. Market size and forecast, by End-User
  - 8.2.6.3. Mexico
  - 8.2.6.3.1. Key market trends, growth factors and opportunities
  - 8.2.6.3.2. Market size and forecast, by Product type
  - 8.2.6.3.3. Market size and forecast, by Property
  - 8.2.6.3.4. Market size and forecast, by Design
  - 8.2.6.3.5. Market size and forecast, by End-User
8.3. Europe
- 8.3.1. Key trends and opportunities
- 8.3.2. Market size and forecast, by Product type
- 8.3.3. Market size and forecast, by Property
- 8.3.4. Market size and forecast, by Design
- 8.3.5. Market size and forecast, by End-User
- 8.3.6. Market size and forecast, by country
  - 8.3.6.1. Germany
  - 8.3.6.1.1. Key market trends, growth factors and opportunities
  - 8.3.6.1.2. Market size and forecast, by Product type
  - 8.3.6.1.3. Market size and forecast, by Property
  - 8.3.6.1.4. Market size and forecast, by Design
  - 8.3.6.1.5. Market size and forecast, by End-User
  - 8.3.6.2. France
  - 8.3.6.2.1. Key market trends, growth factors and opportunities
  - 8.3.6.2.2. Market size and forecast, by Product type
  - 8.3.6.2.3. Market size and forecast, by Property
  - 8.3.6.2.4. Market size and forecast, by Design
  - 8.3.6.2.5. Market size and forecast, by End-User
  - 8.3.6.3. UK
  - 8.3.6.3.1. Key market trends, growth factors and opportunities
  - 8.3.6.3.2. Market size and forecast, by Product type
  - 8.3.6.3.3. Market size and forecast, by Property
  - 8.3.6.3.4. Market size and forecast, by Design
  - 8.3.6.3.5. Market size and forecast, by End-User
  - 8.3.6.4. Italy
  - 8.3.6.4.1. Key market trends, growth factors and opportunities
  - 8.3.6.4.2. Market size and forecast, by Product type
  - 8.3.6.4.3. Market size and forecast, by Property
  - 8.3.6.4.4. Market size and forecast, by Design
  - 8.3.6.4.5. Market size and forecast, by End-User
  - 8.3.6.5. Spain
  - 8.3.6.5.1. Key market trends, growth factors and opportunities
  - 8.3.6.5.2. Market size and forecast, by Product type
  - 8.3.6.5.3. Market size and forecast, by Property
  - 8.3.6.5.4. Market size and forecast, by Design
  - 8.3.6.5.5. Market size and forecast, by End-User
  - 8.3.6.6. Rest of Europe
  - 8.3.6.6.1. Key market trends, growth factors and opportunities
  - 8.3.6.6.2. Market size and forecast, by Product type
  - 8.3.6.6.3. Market size and forecast, by Property
  - 8.3.6.6.4. Market size and forecast, by Design
  - 8.3.6.6.5. Market size and forecast, by End-User
8.4. Asia-Pacific
- 8.4.1. Key trends and opportunities
- 8.4.2. Market size and forecast, by Product type
- 8.4.3. Market size and forecast, by Property
- 8.4.4. Market size and forecast, by Design
- 8.4.5. Market size and forecast, by End-User
- 8.4.6. Market size and forecast, by country
  - 8.4.6.1. China
  - 8.4.6.1.1. Key market trends, growth factors and opportunities
  - 8.4.6.1.2. Market size and forecast, by Product type
  - 8.4.6.1.3. Market size and forecast, by Property
  - 8.4.6.1.4. Market size and forecast, by Design
  - 8.4.6.1.5. Market size and forecast, by End-User
  - 8.4.6.2. Japan
  - 8.4.6.2.1. Key market trends, growth factors and opportunities
  - 8.4.6.2.2. Market size and forecast, by Product type
  - 8.4.6.2.3. Market size and forecast, by Property
  - 8.4.6.2.4. Market size and forecast, by Design
  - 8.4.6.2.5. Market size and forecast, by End-User
  - 8.4.6.3. India
  - 8.4.6.3.1. Key market trends, growth factors and opportunities
  - 8.4.6.3.2. Market size and forecast, by Product type
  - 8.4.6.3.3. Market size and forecast, by Property
  - 8.4.6.3.4. Market size and forecast, by Design
  - 8.4.6.3.5. Market size and forecast, by End-User
  - 8.4.6.4. Australia
  - 8.4.6.4.1. Key market trends, growth factors and opportunities
  - 8.4.6.4.2. Market size and forecast, by Product type
  - 8.4.6.4.3. Market size and forecast, by Property
  - 8.4.6.4.4. Market size and forecast, by Design
  - 8.4.6.4.5. Market size and forecast, by End-User
  - 8.4.6.5. South Korea
  - 8.4.6.5.1. Key market trends, growth factors and opportunities
  - 8.4.6.5.2. Market size and forecast, by Product type
  - 8.4.6.5.3. Market size and forecast, by Property
  - 8.4.6.5.4. Market size and forecast, by Design
  - 8.4.6.5.5. Market size and forecast, by End-User
  - 8.4.6.6. Rest of Asia-Pacific
  - 8.4.6.6.1. Key market trends, growth factors and opportunities
  - 8.4.6.6.2. Market size and forecast, by Product type
  - 8.4.6.6.3. Market size and forecast, by Property
  - 8.4.6.6.4. Market size and forecast, by Design
  - 8.4.6.6.5. Market size and forecast, by End-User
8.5. LAMEA
- 8.5.1. Key trends and opportunities
- 8.5.2. Market size and forecast, by Product type
- 8.5.3. Market size and forecast, by Property
- 8.5.4. Market size and forecast, by Design
- 8.5.5. Market size and forecast, by End-User
- 8.5.6. Market size and forecast, by country
  - 8.5.6.1. Brazil
  - 8.5.6.1.1. Key market trends, growth factors and opportunities
  - 8.5.6.1.2. Market size and forecast, by Product type
  - 8.5.6.1.3. Market size and forecast, by Property
  - 8.5.6.1.4. Market size and forecast, by Design
  - 8.5.6.1.5. Market size and forecast, by End-User
  - 8.5.6.2. Saudi Arabia
  - 8.5.6.2.1. Key market trends, growth factors and opportunities
  - 8.5.6.2.2. Market size and forecast, by Product type
  - 8.5.6.2.3. Market size and forecast, by Property
  - 8.5.6.2.4. Market size and forecast, by Design
  - 8.5.6.2.5. Market size and forecast, by End-User
  - 8.5.6.3. South Africa
  - 8.5.6.3.1. Key market trends, growth factors and opportunities
  - 8.5.6.3.2. Market size and forecast, by Product type
  - 8.5.6.3.3. Market size and forecast, by Property
  - 8.5.6.3.4. Market size and forecast, by Design
  - 8.5.6.3.5. Market size and forecast, by End-User
  - 8.5.6.4. Rest of LAMEA
  - 8.5.6.4.1. Key market trends, growth factors and opportunities
  - 8.5.6.4.2. Market size and forecast, by Product type
  - 8.5.6.4.3. Market size and forecast, by Property
  - 8.5.6.4.4. Market size and forecast, by Design
  - 8.5.6.4.5. Market size and forecast, by End-User

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

10.1. Asahi Kasei Corporation.
- 10.1.1. Company overview
- 10.1.2. Key Executives
- 10.1.3. Company snapshot
- 10.1.4. Operating business segments
- 10.1.5. Product portfolio
- 10.1.6. Business performance
10.2. AngioDynamics, Inc.
- 10.2.1. Company overview
- 10.2.2. Key Executives
- 10.2.3. Company snapshot
- 10.2.4. Operating business segments
- 10.2.5. Product portfolio
- 10.2.6. Business performance
10.3. B. Braun SE
- 10.3.1. Company overview
- 10.3.2. Key Executives
- 10.3.3. Company snapshot
- 10.3.4. Operating business segments
- 10.3.5. Product portfolio
- 10.3.6. Business performance
10.4. Becton, Dickinson and Company
- 10.4.1. Company overview
- 10.4.2. Key Executives
- 10.4.3. Company snapshot
- 10.4.4. Operating business segments
- 10.4.5. Product portfolio
- 10.4.6. Business performance
10.5. ICU Medical Inc.
- 10.5.1. Company overview
- 10.5.2. Key Executives
- 10.5.3. Company snapshot
- 10.5.4. Operating business segments
- 10.5.5. Product portfolio
- 10.5.6. Business performance
10.6. Medtronic plc
- 10.6.1. Company overview
- 10.6.2. Key Executives
- 10.6.3. Company snapshot
- 10.6.4. Operating business segments
- 10.6.5. Product portfolio
- 10.6.6. Business performance
10.7. Merit Medical Systems Inc.
- 10.7.1. Company overview
- 10.7.2. Key Executives
- 10.7.3. Company snapshot
- 10.7.4. Operating business segments
- 10.7.5. Product portfolio
- 10.7.6. Business performance
- 10.7.7. Key strategic moves and developments
10.8. Rex Medical, LLC.
- 10.8.1. Company overview
- 10.8.2. Key Executives
- 10.8.3. Company snapshot
- 10.8.4. Operating business segments
- 10.8.5. Product portfolio
10.9. Teleflex Incorporated
- 10.9.1. Company overview
- 10.9.2. Key Executives
- 10.9.3. Company snapshot
- 10.9.4. Operating business segments
- 10.9.5. Product portfolio
- 10.9.6. Business performance
10.10. Vygon
- 10.10.1. Company overview
- 10.10.2. Key Executives
- 10.10.3. Company snapshot
- 10.10.4. Operating business segments
- 10.10.5. Product portfolio